Yen‐Ling Peng

512 total citations
14 papers, 294 citations indexed

About

Yen‐Ling Peng is a scholar working on Genetics, Hematology and Cancer Research. According to data from OpenAlex, Yen‐Ling Peng has authored 14 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 9 papers in Hematology and 4 papers in Cancer Research. Recurrent topics in Yen‐Ling Peng's work include Acute Myeloid Leukemia Research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Cancer Genomics and Diagnostics (3 papers). Yen‐Ling Peng is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Cancer Genomics and Diagnostics (3 papers). Yen‐Ling Peng collaborates with scholars based in Taiwan, United States and Czechia. Yen‐Ling Peng's co-authors include Ming‐Chih Hou, Jiing‐Chyuan Luo, Wen‐Chien Chou, Chien‐Chin Lin, Hsin‐An Hou, Hwei‐Fang Tien, Yuan‐Yeh Kuo, Mei‐Hsuan Tseng, Cheng‐Hong Tsai and Han‐Chieh Lin and has published in prestigious journals such as Blood, Medicine and Journal of Gastroenterology and Hepatology.

In The Last Decade

Yen‐Ling Peng

13 papers receiving 289 citations

Peers

Yen‐Ling Peng

HEMAT

GENET

SURGE

Sigvard Olsson Sweden

Dieter Lederer Austria

Janel Long‐Boyle United States

McDonald Tp United States

Cristina Boschini Italy

Barbara O’Malley United States

Nadia M T Roodenrijs Netherlands

Ming Zhai China

Alan C. Homans United States

Sigvard Olsson Sweden

Yen‐Ling Peng

141 ×0.8

HEMAT

97 ×1.1

GENET

45 ×0.6

21 ×0.4

17 ×0.3

SURGE

Citations per year, relative to Yen‐Ling Peng Yen‐Ling Peng (= 1×) peers Sigvard Olsson

Countries citing papers authored by Yen‐Ling Peng

Since Specialization

Citations

This map shows the geographic impact of Yen‐Ling Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yen‐Ling Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yen‐Ling Peng more than expected).

Fields of papers citing papers by Yen‐Ling Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yen‐Ling Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yen‐Ling Peng. The network helps show where Yen‐Ling Peng may publish in the future.

Co-authorship network of co-authors of Yen‐Ling Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Yen‐Ling Peng. A scholar is included among the top collaborators of Yen‐Ling Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yen‐Ling Peng. Yen‐Ling Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Tien, Feng‐Ming, Chi‐Yuan Yao, Cheng‐Hong Tsai, et al.. (2024). Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations. Blood Cancer Journal. 14(1). 8 indexed citations

Tsai, Cheng‐Hong, Feng‐Ming Tien, Yuan‐Yeh Kuo, et al.. (2023). Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML. Blood Cancer Journal. 13(1). 4–4. 17 indexed citations

Tsai, Cheng‐Hong, Chien‐Chin Lin, Feng‐Ming Tien, et al.. (2023). Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia. American Journal of Hematology. 98(5). 760–769. 19 indexed citations

Tsai, Cheng‐Hong, Yuan‐Yeh Kuo, Mei‐Hsuan Tseng, et al.. (2022). Prognostic Relevance of Adult Acute Myeloid Leukemia Patients According to the 2022 European Leukemianet Risk Stratiﬁcation. Blood. 140(Supplement 1). 130–131. 2 indexed citations

Lin, Chien‐Chin, Chi‐Yuan Yao, Yuan‐Yeh Kuo, et al.. (2022). Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes. Hematological Oncology. 41(3). 463–473.

Tsai, Cheng‐Hong, Jih‐Luh Tang, Feng‐Ming Tien, et al.. (2021). Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML. Blood Advances. 5(10). 2456–2466. 38 indexed citations

Hou, Hsin‐An, Chien‐Chin Lin, Yuan‐Yeh Kuo, et al.. (2021). A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes. Blood Advances. 5(22). 4535–4548. 20 indexed citations

Tsai, Cheng‐Hong, Chi‐Yuan Yao, Jih‐Luh Tang, et al.. (2019). Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients. EBioMedicine. 40. 240–250. 26 indexed citations

Hou, Hsin‐An, Cheng‐Hong Tsai, Chien‐Chin Lin, et al.. (2018). Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome. Blood Cancer Journal. 8(4). 39–39. 66 indexed citations

10.

Luo, Jiing‐Chyuan, Yen‐Ling Peng, Ping‐Hsien Chen, et al.. (2017). Risk Factors for Upper Gastrointestinal Bleeding in Patients Taking Selective COX-2 Inhibitors: A Nationwide Population-Based Cohort Study. Pain Medicine. 19(2). 225–231. 10 indexed citations

11.

Chen, Tseng‐Shing, Yen‐Ling Peng, Jiing‐Chyuan Luo, et al.. (2017). Cholecystectomy decreased the recurrent cholangitis after clearance of bile duct stones by ERCP in patients with gallstone-related cholangitis. Journal of the Chinese Medical Association. 80(11). 690–696. 5 indexed citations

12.

Peng, Yen‐Ling, Yung‐Tai Chen, Jiing‐Chyuan Luo, et al.. (2016). Cholecystectomy Reduces Recurrent Pancreatitis and Improves Survival After Endoscopic Sphincterotomy. Journal of Gastrointestinal Surgery. 21(2). 294–301. 4 indexed citations

13.

Hu, Hsiao‐Yun, Jiing‐Chyuan Luo, Yen‐Ling Peng, et al.. (2015). Use of SSRI, But Not SNRI, Increased Upper and Lower Gastrointestinal Bleeding. Medicine. 94(46). e2022–e2022. 32 indexed citations

14.

Peng, Yen‐Ling, Hsin‐Bang Leu, Jiing‐Chyuan Luo, et al.. (2013). Diabetes is an independent risk factor for peptic ulcer bleeding: A nationwide population‐based cohort study. Journal of Gastroenterology and Hepatology. 28(8). 1295–1299. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact